Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $435

Benzinga Newsdesk www.benzinga.com Negative 81.5%

Neg 81.5% Neu 0% Pos 0%

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $475 to $435.